The following are the dates, times and co-chairs/faculty information for each of the eight webinars in the series. Registrants will have on-demand access to the recorded seminars, as permitted by the presenters, within 48 hours of the live event.SEMINAR 1 – TGF-beta: A Deep Dive in Cancer Immunotherapy Targets Date of Live Event: 2–4 p.m. EDT on May 26, 2021 (Content now available…
Join SITC and a panel of experts for an afternoon of in-depth education on all aspects of cellular therapies, T Cell Engagers and TIL Therapies
On behalf of the Society for Immunotherapy of Cancer (SITC) and the International Bladder Cancer Group (IBCG), we are pleased to announce the publication of…
Join SITC and a panel of experts for an afternoon of in-depth education on all aspects of clinical implementation of immunotherapy for genitourinary cancers.
The SITC ACCC Expanding Access to Cellular and Bispecific Therapies workshop, SITC and ACCC gathered experts tasked with providing recommendations for centers interested in opening…
Clinical trials frequently include multiple end points that mature at different times. The initial report, typically based on the primary end point, may be published…
Join SITC and a panel of experts for an afternoon of in-depth education on all aspects of clinical implementation of immunotherapy for genitourinary cancers.
The SITC ACCC Expanding Access to Cellular and Bispecific Therapies workshop, SITC and ACCC gathered experts tasked with providing recommendations for centers interested in opening…
Join SITC and a panel of experts for an afternoon of in-depth education on all aspects of clinical implementation of immunotherapy for genitourinary cancers.
On behalf of the Society for Immunotherapy of Cancer (SITC) and the International Bladder Cancer Group (IBCG), we are pleased to announce the publication of…
